Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Lartesertib |
| Synonyms | |
| Therapy Description |
M4076 inhibits ATM, potentially resulting in reduced tumor growth (PMID: 35405736). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Lartesertib | M 4076|M-4076|M4076 | ATM Inhibitor 13 | Lartesertib (M4076) is an ATM inhibitor that potentially decreases tumor growth (PMID: 35405736). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04882917 | Phase I | Lartesertib | First-in-human Study of M4076 in Advanced Solid Tumors (DDRiver Solid Tumors 410) | Completed | USA | CAN | 0 |